交叉呈递：CTL免疫和耐受的一种普遍机制。 - Suppr

Cross-presentation: a general mechanism for CTL immunity and tolerance.

作者信息

Carbone F R, Kurts C, Bennett S R, Miller J F, Heath W R

机构信息

Dept of Pathology and Immunology, Monash Medical School, Victoria, Australia.

出版信息

Immunol Today. 1998 Aug;19(8):368-73. doi: 10.1016/s0167-5699(98)01301-2.

DOI:10.1016/s0167-5699(98)01301-2

PMID:9709505

Abstract

摘要

相似文献

Cross-presentation: a general mechanism for CTL immunity and tolerance.

Immunol Today. 1998 Aug;19(8):368-73. doi: 10.1016/s0167-5699(98)01301-2.

Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells.

Int J Cancer. 2002 Oct 1;101(4):353-9. doi: 10.1002/ijc.10616.

On cross-priming of MHC class I-specific CTL: rule or exception?

Eur J Immunol. 2002 Sep;32(9):2385-92. doi: 10.1002/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V.

The 'chop-and-change' of MHC class I assembly.

Nat Immunol. 2006 Jan;7(1):7-9. doi: 10.1038/ni0106-7.

Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.

Hum Immunol. 2004 Feb;65(2):142-56. doi: 10.1016/j.humimm.2003.12.001.

Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.

Immunol Cell Biol. 1993 Aug;71 ( Pt 4):311-26. doi: 10.1038/icb.1993.36.

Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytes.

Biol Chem Hoppe Seyler. 1994 Nov;375(11):731-6. doi: 10.1515/bchm3.1994.375.11.731.

Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.

J Leukoc Biol. 1994 Nov;56(5):616-24. doi: 10.1002/jlb.56.5.616.

A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells.

J Immunol. 2005 Jun 15;174(12):7497-505. doi: 10.4049/jimmunol.174.12.7497.

Antigen presentation to cytotoxic T lymphocytes in vivo.

J Exp Med. 1995 Sep 1;182(3):639-41. doi: 10.1084/jem.182.3.639.

引用本文的文献

The Immunomodulatory Effect of Different FLT3 Inhibitors on Dendritic Cells.

Cancers (Basel). 2024 Nov 4;16(21):3719. doi: 10.3390/cancers16213719.

The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells.

Cancer Immunol Immunother. 2021 Dec;70(12):3693-3700. doi: 10.1007/s00262-021-02988-3. Epub 2021 Jun 25.

Elotuzumab spares dendritic cell integrity and functionality.

J Cancer Res Clin Oncol. 2021 Jul;147(7):2167-2170. doi: 10.1007/s00432-021-03572-z. Epub 2021 Mar 2.

Combination of Synthetic Long Peptides and XCL1 Fusion Proteins Results in Superior Tumor Control.

Front Immunol. 2019 Feb 26;10:294. doi: 10.3389/fimmu.2019.00294. eCollection 2019.

Inhibition of prostate cancer growth by immunization with a GM-CSF-modified mouse prostate cancer RM-1 cell vaccine in a novel murine model.

Oncol Lett. 2018 Jan;15(1):538-544. doi: 10.3892/ol.2017.7332. Epub 2017 Nov 2.

Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation.

J Vis Exp. 2017 Aug 21(126):55949. doi: 10.3791/55949.

Poly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine.

Sci Rep. 2017 Mar 21;7:44839. doi: 10.1038/srep44839.

Purification of the subcellular compartment in which exogenous antigens undergo endoplasmic reticulum-associated degradation from dendritic cells.

Heliyon. 2016 Sep 8;2(9):e00151. doi: 10.1016/j.heliyon.2016.e00151. eCollection 2016 Sep.

An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets.

J Vis Exp. 2016 Apr 18(110):e53824. doi: 10.3791/53824.

Virus-heat shock protein interaction and a novel axis for innate antiviral immunity.

Cells. 2012 Sep 11;1(3):646-66. doi: 10.3390/cells1030646.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cross-presentation: a general mechanism for CTL immunity and tolerance.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Cross-presentation: a general mechanism for CTL immunity and tolerance.

作者信息

机构信息

出版信息

相似文献

引用本文的文献